BeOne Medicines
James Harris is an accomplished finance professional with extensive experience in financial planning and analysis, strategic leadership, and operational efficiency across various sectors. As the current Director of Finance for UK & Ireland at BeiGene, James oversees business planning, budgeting, and financial performance assessment. Previous roles include Director of FP&A at CooperSurgical, and Associate Director at both Bristol Myers Squibb and Celgene, where responsibilities encompassed financial reporting, performance measurement, and logistical oversight. James's career highlights include leading significant finance transformation projects at Telefónica Europe and Menzies Aviation and developing comprehensive financial reporting systems at Celgene. James holds an MBA from The University of Manchester and a BSc in Economics from Royal Holloway, University of London.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.